Radium-223 dichloride (radium-223), an alpha emitter, selectively targets bone metastases with alpha particles. We assessed the efficacy and safety of radium-223 as compared with placebo, in addition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback